Belamcanda Chinensis

Belamcanda chinensis  (L.) DC.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Iridaceae.
Habitat Introduced from China; cultivated all over India, up to an altitude of 1,800 m.
Folk Surajkaanti (Assam), Dasbaha, Dasbichandi (Bengal).
Action Rhizomes—expectorant, deobstruent, resolvent, used in tonsillitis, chest and liver complaints (antiviral against pneumonia).
Taxonomic Cohort Genus Belamcanda (1 documented species); Family Iridaceae (8 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Belamcanda chinensis (taxonomically cited with authority (L.) DC.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Iridaceae (primary family classification: Iridaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Introduced from China; cultivated all over India, up to an altitude of 1,800 m.

Across classical and vernacular Indian systems of medicine, Belamcanda chinensis is recognized under distinct polyglot nomenclature: in regional Indian folk and vernacular ethnobotany as Surajkaanti (Assam), Dasbaha, Dasbichandi (Bengal). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Belamcanda chinensis are: Rhizomes—expectorant, deobstruent, resolvent, used in tonsillitis, chest and liver complaints (antiviral against pneumonia). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Belamcanda chinensis establish the following evidence base: Presence of alkaloids is reported from the plant, glucoside, belamcandin from the roots. The leaves and flowers contain a glycoflavone. The seeds tested positive for leucoanthocyanins.

image2

Botanical Reference 1: Iris domestica — Botanical specimen

image3

Botanical Reference 2: Iris domestica — Botanical specimen

image4

Botanical Reference 3: Belamcanda chinensis — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Belamcanda chinensis stands as a distinct representative of the genus Belamcanda. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Iridaceae encompasses 8 documented medicinal species (0.44% of the 1,814-species flora). Other representative medicinal members of Iridaceae include: Crocus sativus (Kumkuma), Iris ensata (Paarseeka Vachaa), Iris germanica (Paarseeka Vachaa), Iris kemaonensis (Karkar). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 8 medicinal species of family Iridaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Belamcanda chinensis follow the plant-part modalities specified under its therapeutic action (Rhizomes—expectorant, deobstruent, resolvent, used in tonsillitis, chest and liver complaints (antiviral against pneumonia)), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Belamcanda chinensis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top